1. Huizhuang Shan, Youping Zhang, Xinhua Xiao, Wenxuan Wu, Yingying Wang, Chujiao Zhu1, Wenhui Bai, Ziwei Zhang, Yuanhui Zhai, Li Yang, Yunzhao Wu, Hu Lei, Hanzhang Xu, Yanfei Luo, Liming Lu*, Yingli Wu*. USP7 sustains hematopoietic stem cell homeostasis partially via PU.1 stabilization. International Journal of Biological Sciences. 2026; 22(2): 1036-1052.
2. Shi Qi Li, Yi Wang, Liu Zhang, Ya Ru Yan, Fang Ying Lu, Xi Xi Chen, Ying Ni Lin, Jun Qi Lin, Jian Ping Zhou, Liming Lu*, Qing Yun Li.PFKFB3 Mediated Glycolytic Reprogramming DrivesVascular Endothelial Injury Under Chronic IntermittentHypoxia. International Journal of Biological Sciences. 2026; 22(11): 5735-5753.
3. Feng Z, Li CS, Fu H, Jiang W, Zhang W, Huang Y, Huang Y, Tam TTKK, Li Y, Liu F, Liming Lu, Lee YL, Yeung WSB, Dougan G, Liu P. A Novel Human Cellular System for Studying Normal Aging and for Anti-Aging Discovery. Aging Cell. 2026 Feb;25(2):e70352.
4. Hu Y, Wu L, Qu S, Kong WT, Yu X, Xu J, Xu Z, He J, Wang C, Liu Z, Liming Lu, Ng LG, Blériot C, Su B, Ginhoux F, Li Z, Chakarov S. Temporal and spatial atlas of eosinophil specialization across tissues. Nat Immunol. 2026 Feb;27(2):364-375.
5. Anmin Ren, QianjunLiu, QianGan, Liming Lu, XinKaiQu. Associations of Inflammatory Markers and Coronary Heart Disease in Different Gender Groups in Cohort NHANES 2003-2018. Cardiol Res Pract. 2026 Feb 3;2026:5555602
6. Liu D, Wang X, Han Y, Wang J, Sun Y, Hou Y, Wu Q, Zeng C, Ding X, Chang Y, Hu J, Huang X, Liming Lu*. A donor PD-1+CD8+ TSCM-like regulatory subset mobilized by G-CSF alleviates recipient acute graft-versus-host-disease. Signal Transduct Target Ther. 2025 Apr 2;10(1):120.
7. Ng LG, Ballesteros I, Cassatella MA, Egeblad M, Fridlender ZG, Gabrilovich D, Gao Q, Granot Z, Grieshaber-Bouyer R, Grimes HL, Hedrick CC, Hidalgo A, Kaplan MJ, Kubes P, Ling GS, Liming Lu, Luo HR, Mayadas TN, Moutsopoulos NM, Ng M, Nigrovic PA, Ostuni R, Pittet MJ, Quail DF, Silvestre-Roig C, Soehnlein O, Udalova IA, Xue R, Zhang N, Kwok I. From complexity to consensus: A roadmap for neutrophil classification. Immunity. 2025 Aug 12;58(8):1890-1903.
8. Liu JG, Yu L, Guo XL, He XM, Li M, Gao RY, Zhao BH, Li QY, Zhu WJ, Xu P, Gu XH, Chen YA, Yin XL, Shang Y, Guo ZH, Mao JH, Hu YX, Liming Lu, Hua J, Zhang H, Li Y. Characterizing the immune landscape of tumor-infiltrating lymphocytes in non-small cell lung cancer. Genes Immun. 2025 May 5.
9. Zhang D, Heng Y, Jin QY, Tang D, Zhu XK, Liming Lu*, Wu CP, Tao L. Prognostic significance of cytotoxic-T-lymphocytes to immunosuppressive lymphocytes ratio (CIL) in laryngeal squamous cell carcinoma. Cancer Immunol Immunother. 2025 Mar 24;74(5):157.
10. Zhang L, Lin L, Xiao B, Huang K, Liu J, Chen YL, Liming Lu, Zhang Z, Zhang L, Li J, Ho KT, Luo L, Huang SY, Li G. Eicosapentaenoic acid (EPA) reduced lipopolysaccharide-stimulated inflammatory response of RAW264.7 cells via the miR-125b-5p/CREB axis. Int J Biol Macromol. 2025 May;310(Pt 4):143511.
11. Lin H, Ma J, Heng Y, Zhu X, Jin Q, Ding X, Tao L, Liming Lu*. CD8+ T cells in patients with hypopharyngeal squamous cell carcinoma are susceptible to radiation-induced damage. Int J Cancer. 2025 May 15;156(10):2010-2023.
12. Zhu X, Heng Y, Ma J, Zhang D, Tang D, Ji Y, He C, Lin H, Ding X, Zhou J, Tao L, Liming Lu*. Prolonged Survival of Neutrophils Induced by Tumor-Derived G-CSF/GM-CSF Promotes Immunosuppression and Progression in Laryngeal Squamous Cell Carcinoma. Adv Sci (Weinh). 2024 Dec;11(46):e2400836.
13. Zhang Y, Ding X, Zhang Q, Zeng C, Chen H, Liming Lu*. Trichosanthin elicits antitumor activity via MICU3 mediated mitochondria calcium influx. J Adv Res. 2024 Nov 4:S2090-1232(24)00493-4.
14. Wang QL, Lu SY, Xu DD, Ma JX, Guo R, Zhang L, Tang LY, Shen Y, Shen CL, Wang JJ, Wu YL, Liming Lu, Wang ZG, Zhang HX. USP47 deficiency in mice modulates tumor infiltrating immune cells and enhances antitumor immune responses in prostate cancer. Cancer Immunol Immunother. 2024 Jun 4;73(8):143.
15. Qu X, Guan S, Cai J, Gan Q, Han W, Liming Lu, Fang W, Yin P, Shi H, Wang A, G Y, Zhou M, Huo Y. Reperfusion strategies on the clinical outcomes of ST-elevation myocardial infarction patients over 80 years old in China. Eur Heart J Qual Care Clin Outcomes. 2024 Feb 9:qcae013.
16. Ji Y, Heng Y, Zhu X, Zhang D, Tang D, Zhou J, Lin H, Ma J, Ding X, Tao L, Liming Lu*. Increased tumor-infiltrating plasmacytoid dendritic cells express high levels of PD-L2 and affect CD8+ T lymphocyte infiltration in human laryngeal squamous cell carcinoma. Transl Oncol. 2024 Jul;45:101936.
17. Ma J, Zhu X, Heng Y, Ding X, Tao L, Liming Lu*. Establishment and characterization of a novel hypopharyngeal squamous cell carcinoma cell line CZH1 with genetic abnormalities. Hum Cell. 2024 Mar;37(2):546-559.
18. Zhu X, Heng Y, Zhang D, Tang D, Zhou J, Lin H, Ma J, Ding X, Tao L, Liming Lu*. Prognostic significance and immune escape implication of tumor-infiltrating neutrophil plasticity in human head and neck squamous cell carcinoma. Hum Cell. 2024 May;37(3):714-728.
19. Zhou D, Xu W, Ding X, Guo H, Wang J, Zhao G, Zhang C, Zhang Z, Wang Z, Wang P, Lu L, Yuan M. Transient inhibition of neutrophil functions enhances the antitumor effect of intravenously delivered oncolytic vaccinia virus. Cancer Sci. 2024 Apr;115(4):1129-1140.
20. Yuanyuan Mei, Xiaoting Sun, Shi-Ying Huang, Xiaowen Wu, Kuo-Ting Ho, Liming Lu, Chaoxiang Chen, Jian Li, Jingwen Liu, Guiling Li. Curcumin Prevents Free Fatty Acid-Induced Lipid Accumulation via Targeting the miR-22-3p/CRLS1 Pathway in HepG2 Cells. Polish Journal of Food and Nutrition Sciences. 2024; 74(1): 59–68
21. Jie Shu, Kefan Wang, Yuting Liu, Jie Zhang, Xuping Ding, Hanxiao Sun, Jiaoxiang Wu, Biao Huang, Ju Qiu, Huiming Sheng, Liming Lu*. Trichosanthin alleviates streptozotocin-induced type 1 diabetes mellitus in mice by regulating the balance between bone marrow-derived IL6+ and IL10+ MDSCs. Heliyon. 2023 Dec 12;10(1):e22907.
22. Heng Y, Zhu X, Wu Q, Lin H, Ding X, Tao L, Liming Lu*. High Expression of Tumor HLA-DR Predicts Better Prognosis and Response to Anti-PD-1 Therapy in Laryngeal Squamous Cell Carcinoma. Transl Oncol. 2023 Jul;33:101678.
23. Zhou L, Hou Y, Pan X, Wang X, Jin H, Yang X, Wang K, Ding X, Wang K, Zhu M, Pan Y, Wang W, Liming Lu*. Trichosanthin-derived peptide Tk-PQ attenuates immune rejection in mouse tracheal allotransplant model by suppressing PI3K-Akt and inducing type II immune polarization. Int Immunopharmacol. 2023 Oct 18;125(Pt A):111081.
24. Zhang D, Tang D, Liu PT, Tao L, Liming Lu*. Isolation of tumor stem-like cells from primary laryngeal squamous cell carcinoma cells (FD-LS-6). Hum Cell. 2023 Sep 27.
25. Lv QM, Lei HM, Wang SY, Zhang KR, Tang YB, Shen Y, Liming Lu*, Chen HZ, Zhu L. Cancer cell-autonomous cGAS-STING response confers drug resistance. Cell Chem Biol. 2023 Jun 15;30(6):591-605.e4.
26. Heng Y, Zhu XK, Lin HQ, Ma JY, Ding XP, Zhang D, Tang D, Tao L, Liming Lu*. CD206+ tumor-associated macrophages interact with CD4+ tumor-infiltrating lymphocytes and predict adverse patient outcome in human laryngeal squamous cell carcinoma. Journal of Translational Medicine2023 Mar 3;21(1):167
27. Yuting Liu, Kefan Wang, Shuofei Yang, Guanhua Xue, Liming Lu*. Mulberry extract upregulates cholesterol efflux and inhibitsp38 MAPK-NLRP Mediated inflammation in foam cells. Food Sci Nutr. 2023 Mar 8;11(6):3141-3153.
28. Ruan D, Ye ZW, Yuan S, Li Z, Zhang W, Ong CP, Tang K, Ka Ki Tam TT, Guo J, Xuan Y, Huang Y, Zhang Q, Lee CL, Liming Lu, Chiu PCN, Yeung WSB, Liu F, Jin DY, Liu P. Human early syncytiotrophoblasts are highly susceptible to SARS-CoV-2 infection. Cell Rep Med. 2022 Dec 20;3(12):100849.
29. Lei HM, Zhang KR, Wang CH, Wang Y, Zhuang GL, Liming Lu, Zhang J, Shen Y, Chen HZ, Zhu L. Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas. Theranostics. 2019 Sep 23;9(24):7122-7139.
30. Wang T, Zhang D, Tang D, Heng Y, Liming Lu*, Tao L. The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 2022 Dec 15.
31. Ma JX, Xu DD, Lu SY, Wang QL, Zhang L, Guo R, Tang LY, Shen Y, Shen CL, Wang JJ, Liming Lu, Wang ZG, Zhang HX. Stk10 Deficiency in Mice Promotes Tumor Growth by Dysregulating the Tumor Microenvironment. Biology (Basel). 2022 Nov 15;11(11):1668.
32. Han Y, Ouyang X, Chen Y, Lai S, Sun H, Wu N, Ruan C, Liming Lu, Su B. scRNA-seq profiling of neonatal and adult thymus-derived CD4+ T cells by a T cell origin-time tracing model. J Mol Cell Biol. 2022 Dec 20:mjac072.
33. Rui Guo, Shun-Yuan Lu, Jin-Xia Ma, Qian-Lan Wang, Lu Zhang, Ling-Yun Tang, Yan Shen, Chun-Ling Shen, Jin-Jin Wang, Liming Lu, Zhu-GangWang, Hong-Xin Zhang, RIG-I acts as a tumor suppressor in melanoma via regulating the activation of the MKK/p38MAPK signaling pathway. Hum Cell. 2022 Jul;35(4):1071-1083.
34. Di Tang, Duo Zhang, Yu Heng, Xiao-ke Zhu, Han-qing Lin, Jian Zhou, Lei Tao*, and Liming Lu*, Tumor-infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis. Journal of Inflammation Research. 2022 Feb. 16;15:1079-1097 4.2
35. ZongAn Chen, Zhen Gao, LingLing Xia, XiaoQing Wang, Liming Lu*, XiaoLi Wu *. Dysregulation of DPP4-CXCL12 balance by TGF-β1/SMAD pathway promotes CXCR4+ inflammatory cell infiltration in keloid scars.Journal of Inflammation Research. 2021 Aug 26;14:4169-4180.
36. Kai Wang, Man Zhang, Jiao Wang, Jizhuang Luo, Pan Sun, Haizhen Jing, Rong Li, Changqing Pan, Liming Lu*. A systematic analysis identifies key regulators involved in cell proliferation and potential drugs for the treatment of human lung adenocarcinoma.Frontiers in Oncology-Thoracic Oncology.2021 Sep28;11:4-15
37. Huidong Guo, Ruifeng Li, Ming Wang, Yingping Hou, Shuoshuo Liu, Ting Peng, Xiang-Yu Zhao, Liming Lu, Yali Han, Yiming Shao, Yingjun Chang, Cheng Li, and Xiaojun Huang. Multiomics Analysis Identifies SOCS1 as Restraining T cell Activation and Preventing GVHD.J Exp Med . 2021Oct 09
38. Ke-Ren Zhang , Yu-Fei Zhang , Hui-Min Lei , Ya-Bin Tang , Chun-Shuang Ma , Qian-Ming Lv , Shi-Yi Wang , Liming Lu, Ying Shen , Hong-Zhuan Chen , Liang Zhu Targeting AKR1B1 inhibits glutathione de novo synthesis to overcome acquired resistance to EGFR- targeted therapy in lung cancer. Sci Transl Med2021 Oct 6;13(614):eabg6428.
39. Duo Zhang;Di Tang;Yu Heng; Xiao-Ke Zhu;Liang Zhou; Lei Tao; Liming Lu*. Prognostic Impact of Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Patients. Laryngoscope. 2021 Apr;131(4):E1249-E1255
40. Christopher D Nishimura, Marc C Pulanco, Wei Cui, Liming Lu, Xingxing Zang PD-L1 and B7-1 Cis-Interaction: New Mechanisms in Immune Checkpoints and Immunotherapies. Trends Mol Med.2020 Nov13;S1471-4914(20)30266-5.
41. ZhangYu; Zhou Lin; GuXiang; FengXuan; Ding Ping; Xia Qiang; Liming Lu*. CXCL8high inflammatory B cells in the peripheral blood of patients with biliary atresia are involved in disease progression. Immunology & Cell Biology.2020; 1–11
42. Zhang, Na; Sun, Pan; Jin, Haizhen; Yang, Yuqin; Zhao, Qingya; Zhou, Lin; Guo, Lili; Yang, Xiaohua; Liming Lu*.Chidamide combined with paclitaxel effectively reverses the expression of histone deacetylase in lung cancer.Anti-Cancer Drugs. 2020 August; 31(7):702-708,
43. Yi Xue , Di Tang , Sheng-Jie Li , Jian Zhou , Chi-Yao Hsueh , Dan-Dan Zhao , Yu Heng , Lei Tao, Liming Lu*. Link Between CIITA rs3087456 Polymorphism and the Risk of Laryngeal Squamous Cell Carcinoma in a Chinese Population.Pathol Res Pract. 2020 Jan;216(1):152793.
44. Jian Zhou, Liang Zhou, Duo Zhang, Wei-Jing Tang, Di Tang, Xiao-Ling Shi, Yue Yang, Lin Zhou, Fei Liu, Yong Yu, Pentao Liu, Lei Tao, Liming Lu*. BCL11A Promotes the Progression of Laryngeal Squamous Cell Carcinoma. Front Oncol. 2020;10:375.
45. HeYu-Bin; GuoJiang-Hong; WangChong; ZhuDan; Liming Lu*. IL-33 promotes the progression of nonrheumatic aortic valve stenosis via inducing differential phenotypic transition in valvular interstitial cells. Journal of cardiology.2020 Feb;75(2):124-133.
46. Gao, Xuefei; Nowak-Imialek, Monika; Chen, Xi; Chen, Dongsheng; Herrmann, Doris; Ruan, Degong; Chen, Andy Chun Hang; Eckersley-Maslin, Melanie A; Ahmad, Shakil; Lee, Yin Lau; Kobayashi, Toshihiro; Ryan, David; Zhong, Jixing; Zhu, Jiacheng; Wu, Jian; Lan, Guocheng; Petkov, Stoyan; Yang, Jian; Antunes, Liliana; Campos, Lia S; Fu, Beiyuan; Wang, Shengpeng; Yong, Yu; Wang, Xiaomin; Xue, Song-Guo; Ge, Liangpeng; Liu, Zuohua; Huang, Yong; Nie, Tao; Li, Peng; Wu, Donghai; Pei, Duanqing; Zhang, Yi; Liming Lu; Yang, Fengtang; Kimber, Susan J; Reik, Wolf; Zou, Xiangang; Shang, Zhouchun; Lai, Liangxue; Surani, Azim; Tam, Patrick P L; Ahmed, Asif; Yeung, William Shu Biu; Teichmann, Sarah A; Niemann, Heiner; Liu, Pentao. Establishment of porcine and human expanded potential stem cells. Nature cell biology, 2019, 21(6): 687. Establishment of porcine and human expanded potential stem cells. Nature cell biology, 2019, 21(6): 687.
47. Lin Ye, Yuqing Lou, Liming Lu and Xiaohong Fan. Mesothelin-targetedsecond generationCAR-T cellsinhibit growthof mesothelin-expressing tumorsin vivo. Exp Ther Med. 2019 Jan;17(1):739-747.
48. Yuanyuan Li, Mengyue Niu, Aonan Zhao, Wenyan Kang, Zhichun Chen, Ningdi Luo, Liche Zhou, Xiongwei Zhu, Liming Lu* and Jun Liu*. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease. Journal of Neuroinflammation. 2019;16(1):263.
49. Yi xue, Huai-Dong Du, Di Tang, Duo Zhang, Jian Zhou, Chang-Wen Zhai, Cun-Cun Yuan, Chi-Yao Hsueh, Sheng-Jie Li, Yu Heng, Lei Tao and Liming Lu*. Correlation Between the NLRP3 Inflammasome and the Prognosis of Patients With LSCC. FRONTIERS IN ONCOLOGY , 2019 , Jul 2;9:588
50. Tu, G. W., Ju, M. J., Zheng, Y. J., Hao, G. W., Ma, G. G., Hou, J. Y., Zhang, X. P., Luo, Z., Liming Lu* CXCL16/CXCR6 is involved in LPS-induced acute lung injury via P38 signalling. Journal of cellular and molecular medicine, 2019 Aug;23(8):5380-5389.
51. Jun Lu, Hua Zhong, Tianqing Chu, Xueyan Zhang, Rong Li, Jiayuan Sun, Runbo Zhong, Yuqin Yang, Mohammad Shah Alam, Yuqing Lou, Jianlin Xu, Yanwei Zhang, Jun Wu, Xiaowei Li, Xiaodong Zhao, Kai Li, Liming Lu*, Baohui Han. Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for non-small cell lung cancer therapy. European Respiratory Journal . 2019 Mar 1;53(3). pii: 1801562.
52. Ma X, Li B, Li Y, Liming Lu, Chen H. A Pathologic Complete Response to Neoadjuvant Chemotherapy and Immunotherapy Followed by Surgery in a Patient With NSCLC. J Thorac Oncol. 2019 May;14(5):e104-e106.
53. Shen Y, Yan Y, Liming Lu, Qian Y, Guan X, Zhang L, Qi Y, Gu L, Ding F. Klotho ameliorates hydrogen peroxide-induced oxidative injury in TCMK-1 cells. Int Urol Nephrol. 2018 Apr;50(4):787-798.
54. Tang D, Zhao D, Wu Y, Yao R, Zhou L, Liming Lu*, Gao W, Sun Y. The miR-3127-5p/p-STAT3 axis up-regulates PD-L1 inducing chemoresistance in non-small-cell lung cancer. J Cell Mol Med. 2018 Aug;22(8):3847-3856.
55. Tang D, Yao R, Zhao D, Zhou L, Wu Y, Yang Y, Sun Y, Liming Lu*, Gao W. Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy. Sci Rep. 2018 Mar 2;8(1):3917.
56. Weimin Fan, Yali Xu, Yue Liu , Zhengqing Zhang , Liming Lu* and Zhide Ding，Obesity or Overweight, a Chronic Inflammatory Status in Male Reproductive System, Leads to Mice and Human Subfertility. Frontiers in Physiology, 2018,8:1117.
57. Xiaoyan Yu, Yimin Lao, Xiao-Lu Teng, Song Li, Yan Zhou, Feixiang Wang, Xinwei Guo, Siyu Deng, Yuzhou Chang, Xuefeng Wu, Zhiduo Liu, Lei Chen, Liming Lu, Jinke Cheng, Bin Li, Bing Su, Jin Jiang, Hua-Bing Li, Chuanxin Huang, Jing Yi & Qiang Zou . SENP3 maintains the stability and function of regulatory T cells via BACH2 deSUMOylation[J]. Nature communications, 2018, 9(1): 3157.
58. Xiaoyan Yu, XiaoLu Teng, Feixiang Wang, Yuhan Zheng, Guojun Qu, YanZhou, Zhilin Hu, Zhongqiu Wu, Yuzhou Chang, Lei Chen,HuaBing Li, Bing Su, Liming Lu*, Zhiduo Liu, ShaoCong Sun, and Qiang Zou. Metabolic control of regulatory T cell stability and function by TRAF3IP3 at the lysosome. J Exp Med . 2018 Sep 3;215(9):2463-2476.
59. Yue Wang, Qing Li, Lin Zhou, Xueping Ding, Liming Lu*. Peptede TK-PQ induces immunosuppression in skin allogeneic transplantation via increasing Foxp3+ Treg and impeding nuclear translocation of NF-κB. Molecular Immunology.2018 Sep;101:597-607.
60. Xiao-yang Zhang, Lin Zhou, Zhen Guo, Ye Kong, Wei Zhang, Liming Lu*，Xin Li*, Regulatory T Cells may Play an Protection Role in Lung Injury after Operation in Rheumatic Heart Disease. Journal of Thoracic Disease, 2018 Jun;10(6):3196-3205.
61. ZongAn Chen*, Lin Zhou*, TaeHao Won, Zhen Gao, XiaoLi Wuand Liming Lu*. .Characterization of Memory T Lymphocytes in Keloid Disease.Br J Dermatol. 2018 Apr;178(4):940-950.
62. Yang Jian,Ryan David J,Wang Wei,Jason Cheuk-Ho Tsang, Guocheng Lan, Hideki Masaki, Xuefei Gao, Liliana Antunes, Yong Yu, Zhexin Zhu, Juexuan Wang, Aleksandra A. Kolodziejczyk, Lia S. Campos, Cui Wang, Fengtang Yang, Zhen Zhong, Beiyuan Fu, Melanie A. Eckersley-Maslin, Michael Woods, Yosuke Tanaka, Xi Chen, Adam C. Wilkinson, James Bussell, Jacqui White, Ramiro Ramirez-Solis, Wolf Reik, Berthold Göttgens, Sarah A. Teichmann, Patrick P. L. Tam, Hiromitsu Nakauchi, Xiangang Zou, Liming Lu, Pentao Liu*. Establishment of mouse expanded potential stem cells.[J] .Nature, 2017, 550(7676): 393-397.
63. Zhang D, Zhou J, Tang D, Lei Tao, Liming Lu*. Neutrophil infiltration mediated by CXCL5 accumulation in the laryngeal squamous cell carcinoma microenvironment: A mechanism by which tumour cells escape immune surveillance. Clinical Immunology, 2017, 175: 34-40.
64. Tang Wei-Jing,Tao Lei, Liming Lu* et al. Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma.[J] .Oncol Lett, 2017, 14(1): 561-568.
65. Zhou, J., Yang, Y., Zhang, D., Zhou, L., Tao, L., & Liming Lu*. Genetic polymorphisms and plasma levels of BCL11A contribute to the development of laryngeal squamous cell carcinoma. PloS one, 2017 Feb 22;12(2):e0171116.
66. Yu, Y, Tsang, C-H. J, Wang, C, Simon Clare, Juexuan Wang,Xi Chen, CordeliaBrandt, Leanne Kane, Lia S. Campos, Liming Lu, Gabrielle T. Belz, Andrew N. J. McKenzie,Sarah A.Teichmann, Gordon Dougan& Pentao Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its developmental pathway. Nature. 2016 Sep;539(7627)
67. Zhang, D, W. J. Tang, D. Tang, J. Zhou, L. Chou, L. Tao & Liming Lu*. The ratio of CD4/CD8 T-cells in human papillomavirus-positive laryngeal squamous cell carcinoma accounts for improved outcome. Acta Otolaryngol, 2016.136, 826-33.
68. Zhou, J, Y. Yang, D. Zhang, L. Zhou, F. Liu, L. Tao, Liming Lu*. Association of the recurrence of vocal leukoplakia with MDM2-309 variants over a 2-year period: a prospective study. Acta Otolaryngol, 2016.136, 95-9.
69. ZhouJ, D.Zhang, L. Zhou, Y. Yang, F. Liu, L. Tao, Liming Lu*. Association of the recurrence and canceration rate of vocal leukoplakia with interleukin-10 promoter variants over a 2-year period. Acta Otolaryngol, 2016. 136, 1147-1153.
70. Li Z, Yang N, Zhou L, Gu P, Wang H, Zhou Y, Zhou P, Liming Lu*, Chou KY. A peptide tetramer Tk-tPN induces tolerance of cardiac allografting by conversion of type 1 to type 2 immune responses via the Toll-like receptor 2 signal-promoted activation of the MCP1 gene. Immunology. 2016 Mar;147(3):355-66.
71. Tang D, Tang WJ, Shi XL, Li WP, Zhou H, Liming Lu*, Tao L. Association of the microsatellite (GT)n repeat polymorphisms of the HO-1 gene promoter and corresponding serum levels with the risk of laryngeal squamous cell carcinoma. Acta Otolaryngol. 2016 Aug;136(8):806-11.
72. Zhao AM, Xu HJ, Kang XM, Zhao AM, Liming Lu*.New insights into myeloid-derived suppressor cells and their roles in feto-maternal immune cross-talk. J Reprod Immunol. 2016 Nov 10;113:35-41.
73. Zhang D, Chen B, Zhou J, Zhou L, Li Q, Liu F, Chou KY, Tao L, Liming Lu*. Low concentration of Trichosanthin induces apoptosis and cell cycle arrest through JNK/MAPK activation. Molecular Medicine Report. 2015 Jan;11(1):349-56.
74. Zhou J, Yang Y, Zhang D, Zhou L, Liu F, Tao L, Liming Lu*. Association of the recurrence of vocal leukoplakia with MDM2-309 variants over a 2-year period: a prospective study. Acta oto-laryngologica 2015:1-5.
75. Yu Y, Wang C, Clare S, Wang J, Lee SC, Brandt C, Burke S1, Liming Lu , He D, Jenkins NA, Copeland NG, Dougan G, Liu P.. The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development. The Journal of experimental medicine 2015;212:865-74.
76. Tsang JC, Yu Y, Burke S, Buettner F, Wang C, Kolodziejczyk , Teichmann SA, Liming Lu*, Liu P, Single-cell transcriptomic reconstruction reveals cell cycle and multi-lineage differentiation defects in Bcl11a-deficient hematopoietic stem cells. Genome Biol. 2015 Sep 21;16(1):178. doi:10.1186/s13059-015-0739-5.
77. Yang J, Wang W, Ooi J, Campos LS, Liming Lu*, Liu P Signalling Through Retinoic Acid Receptors is Required for Reprogramming of Both Mouse Embryonic Fibroblast Cells and Epiblast Stem Cells to Induced Pluripotent Stem Cells. Stem Cells. 2015 May 33(5):1390-404.
78. Xuefei Gao, Jason C.H. Tsang, Fortis Gaba, Donghai Wu, Liming Lu*, Pentao Liu Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers. Nucleic Acids Research, 2014 2014 Nov 10;42(20):e155.
79. Tsang JC, Xuefei Gao, Liming Lu*, Pentao Liu Cellular reprogramming by transcription factor engineering. Current Opinion in Genetics & Development 2014, 28:1–9
80. Jian Zhou, Duo Zhang, Bin Chen, Qing Li, Lin Zhou, Fei Liu, Kuang-Yen Chou, Lei Tao, Liming Lu*. Association of interleukin‑10 promoter polymorphisms and corresponding plasma levels with susceptibility to laryngeal squamous cell carcinoma ONCOLOGY LETTERS. 2014,7: 1721-1727.
81. F. Liu, X. Pan, L. Zhou, B. Chen, J. Shi, W. Gao and Liming Lu*. Genetic polymorphism and plasma levels of interleukin-22 contribute to the development of nonsmall lung cancer. DNA and CellBiology. 2014 Oct;33(10):705-14.
82. Zhou J, Liu F, Zhang D, Chen B, Li Q, Zhou L, Liming Lu*, Tao L. Significance of MDM2-309 polymorphisms and induced c orresponding plasma MDM2 levels in susceptibility to laryngeal squamous cell carcinoma DNA Cell Biol. 2014 Feb;33(2):88-94.
83. Neng Yang, Zuoqing Li, Zhijun Jiao, Peng Gu, Yun Zhou, Liming Lu*, Kuang-Yen Chou A Trichosanthin-derived peptide suppresses type 1 immune responses by TLR2-dependent activation of CD8+CD28−Tregs Clinic immunology (2013), 153, 277–287.
84. Bin Chen, Duo Zhang, Jian Zhou, Qing Li, Lin Zhou, Shi-Min Li, Li Zhu, Kuang-Yen Chou, Liang Zhou, Lei Tao, Liming Lu*. High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma. ONCOLOGY REPORTS 2013 30: 1380-1390.
85. Yang ZQ, Yang N, Zhou Y, Xin LJ, Liming Lu*, Chou KY. Mutated MHC class II transactivator upregulates IL-33-dependent differentiation of Th2 subset through Nod2 binding for NLR signaling initiation. Journal of Biological Chemistry, 2012 Mar 23;287(13) :9972-9981
86. Liu Y, Qu F, Cao X, Chen G, Guo Q, Ying X, Guo W, Liming Lu*, Ding Z.Con A-binding protein Zn-α2-glycoprotein on human sperm membrane is related to acrosome reaction and sperm fertility. International Journal of Andrology. 2012 Apr;35(2):145-157
87. Ding Q, Liming Lu*, Xiaorong Zhou, Zhou Y, Chou KY. Human PD-L1-overexpressing porcine vascular endothelial cells induce functionally suppressive human CD4+CD25hiFoxp3+ Treg cells. Journal of Leukocyte Biology, 2011 Jul, 90 (1):77-86.
88. Wang B, Jiao Z, Shao X, Liming Lu, Yang N, Zhou X, Xin L, Zhou Y, Chou KY. Phenotypic alterations of dendritic cells are involved in suppressive activity of trichosanthin-induced CD8+CD28- regulatory T cells. Journal of Immunology. 2010 Jul 1: 185(1):79-88
89. Zhou XR, Zhou Y, Ding Q, Liming Lu, Yang N, Chou KY. High level expression of B7H1 molecules by keratinocytes suppresses xeno- and allo- eactions by inducing type I regulatory T cells TransplantImmunology, 2009, 21: 192-197
90. Zhang J, Chen X, Zhang S, Zhou G, Xia X, Liming Lu*. Effects of transdermal estrogen therapy on expressions of estrogen receptors and T-lymphocyte apoptosis in surgically menopausal women. Cell Mol Immunol. 2009 Aug;6(4):277-83.
91. Zhou XR, Yang N, Liming Lu, Ding Q, Jiao ZJ, Zhou Y, Chou KY. Up-regulation of IL-10 expression in dendritic cells is involved in Trichosanthin-induced immuno- suppression. Immunol Let 2007, 74-81.
92. Xiaorong Zhou,YangJiang, Liming Lu, Qing Ding,Kuang-Yen Chou. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation. Immunol, 2007,122,476-485.
93. Ding Q，Liming Lu, Wang BL, Zhou Y, Chou KY. B7H1-Ig fusion protein activates the CD4+IFNreceptor+ type 1 T regulatory subset through IFN-g-secreting Th1 cells. Journal of Immunology, 2006,177：3606-14.
94. 王克凡, 路丽明*.免疫细胞：调控脂肪组织产热与代谢紊乱的关键[J].现代免疫学,2025,45(05):493-501.
95. 胡雅楠,王克凡, 路丽明*, Svetoslav Chakarov等.嗜酸性粒细胞在肥胖及相关疾病中的作用[J].现代免疫学,2025,45(02):89-95.
96. 丁旭苹,王克凡,曾聪, 路丽明*.中药天花粉蛋白荧光纳米颗粒的制备及其免疫调节功能探究[J].中国医药导报,2025,22(24):28-33.
97. 张铎,路丽明*.肿瘤相关中性粒细胞的异质性及潜在的临床意义.中国肿瘤生物治疗杂志. 2024,31(04)
98. 王雪,潘旭峰,丁旭苹,杨骏,侯亚菲,金海振,潘雁,祝敏芳,王韡旻,潘常青, 路丽明*.同种异体肺移植术后血浆IL-10水平变化及与受者发生临床细菌感染死亡的关联[J].现代免疫学,2024,44(01):1-9+25.
99. 王雪,路丽明*. IRF4：调控多种免疫细胞谱系分化及命运决定的关键分子[J].现代免疫学,2024,44(02):89-96.
100. 杨颖,李子涵,丁旭苹,张嘉敏，李勤，郭忠慧，赵俸涌，杨启修，王晨，路丽明，朱自严.肿瘤抗原肽的HLA限制性确认和诱导反应性T细胞杀瘤能力评估[J].临床输血与检验,2024,26(04):433-439.
101. 时念民,李林康,邵祝军,张文宏,吴疆,吕敏,郑佳音,陈直平,刘晓强,张宏,谭颖,刘小荣,赵明辉,罗哲,吕继成,路丽明*.补体相关性肾病人群中脑膜炎球菌疫苗和补体抑制剂联用的专家共识[J].慢性病学杂志, 2023, 24(08): 1156-1159.
102. 贾婧懿;陈启焓;张心瑜;白庭月;路丽明*.CD8~+Treg:亚群异质性及免疫生物学特性[J].现代免疫学,2023,43(06):522-528.
103. 林瀚青, 陶磊, 路丽明*.CD4~+调节性T细胞：功能异质性、分群与疾病.现代免疫学, 2022, 42(02): 89-96.
104. 杨颖,路丽明,李勤,郭忠慧,杨启修,张嘉敏,赵俸涌,王晨,朱自严.肿瘤新抗原肽诱导献血者PBMC特异反应性T细胞[J].临床输血与检验，2022，24(05):565-573.
105. 宣彬彬,丁旭苹,侯亚菲,王雪,武娇祥,孙寒晓,谭美玉,盛慧明,路丽明*.天花粉蛋白通过影响Foxp3的泛素化水平增强CD4~+Treg的体外诱导的初步研究[J].现代免疫学,2022,42(03):185-192.
106. 杨颖,路丽明,李勤,等.肿瘤新抗原肽诱导献血者PBMC特异反应性T细胞[J].临床输血与检验,2022,24(05):565-573.
107. 杨晓华,郭莉莉,路丽明*.耐紫杉醇肺原位小鼠移植瘤模型的建立和鉴定.中国实验动物学报2021年03期:275-283页
108. 丁旭苹;王雪;路丽明*.中药天花粉蛋白增强诱导CD4~+CD25~+Foxp3~+调节性T细胞数量和功能的初探[J].世界科学技术-中医药现代化,2021,23(11):4097-4108.
109. 汤成捷,疏龙强,吴缘开,赵良娟,张亦凡,侯亚菲,路丽明*.中性粒细胞的免疫抑制亚群及功能和机制研究进展.细胞与分子免疫学杂志, 2020年09期:833-842页
110. 费腾,李从镇,路丽明*.TIM-3分子与肿瘤免疫抑制.中国肿瘤生物治疗杂志 2020,27(02),199-203
111. 薛乙,汤迪,翟长文,袁存存,衡宇,周梁,陶磊,路丽明*CⅡTA表达与喉鳞状细胞癌（LSCC）患者预后的关系.复旦学报(医学版). 2020年02期第192-196.
112. 商占仙, 路丽明*中性粒细胞在肿瘤发生、发展中的研究进展.现代免疫学. 2018年06期488-492.
113. 衡宇, 查亚芳, 顾燕妮, 沈朝斌，路丽明*. 2018 年美国儿童预防接种最新指南解读及其与我国现状比较. 现代免疫学, 2018, 38(04): 350-353.
114. 李健,郭震,路丽明*,李欣.无血预充大鼠体外循环模型的建立[J].中国体外循环杂志,2018,16(03):184-188.
115. 陈广洁, 谢长宜, 钮晓音,蒋黎华, 聂红, 路丽明, 席晔斌, 葛海良. 机体防御与免疫整合课程的实践与研究[J]. 中国高等医学教育, 2018 (4): 16-17.
116. 张晓阳，路丽明*，李欣调节性T 细胞和辅助性T细胞与体外循环后肺损伤相关性的研究中国体外循环杂志 2017,15:81-85 通讯作者
117. 万建伟，周琳，赵丹丹，杨玉琴，路丽明*. 联烯化合物 PHPO 对肺癌细胞株 A549 增殖及凋亡的影响上海交通大学学报（医学版）2017,37:1433-1439
118. 于浩然，张柳蕙，刘威，周琳，丁旭苹，蒋黎华，路丽明*. RBL教学对临床医学本科生综合能力培养的作用.中华医学教育探索杂志, 2016, 15(10): 1034-1038.
119. 周琳，高文，路丽明*. 肺移植后闭塞性细支气管炎免疫学发病机制及治疗新策略现代免疫学2016, 36:67-71 通讯作者
120. 胡敏娟，那君，胡婧雯，杨小茜，衡宇，路丽明*. 病原生物相关蛋白作为人类疫苗佐剂的研究进展现代免疫学2016, 36:242-244 通讯作者
121. 杨小茜，胡婧雯，那君，胡敏娟，衡宇，路丽明*. 非细胞因子来源的天然蛋白质作为人类疫苗佐剂的研究进展现代免疫学2016, 36:245-249 通讯作者
122. 那君，杨小茜，胡婧雯，胡敏娟，衡宇，路丽明*. 细胞因子来源的天然蛋白质作为人类疫苗佐剂的研究进展现代免疫学2016, 36:337-340 通讯作者
123. 刘菲，徐艺，周光炎，路丽明*. CD8+Treg 的免疫生物学特征及其与疾病的关系现代免疫学2014, 34:61-66 通讯作者
124. 刘菲, 潘旭峰, 周琳, 路丽明*. 肺腺癌患者血浆microRNA-10b 表达及临床意义. 中华实用诊断与治疗杂志, 2014, 28(9): 846-848. 通讯作者
125. 刘菲, 周光炎, 路丽明*. 胞内模式识别受体NLR 的生物学特性及其在疾病中的作用[J]. 中国免疫学杂志, 2014, 12: 032.
126. 周琳，刘菲，周光炎，路丽明*. 天花粉蛋白对结肠癌细胞株CMT-93 凋亡及增殖的影响上海交通大学学报（医学版）2014,34(3):257-262. 通讯作者
127. 沈玥, 路丽明*，钱盈盈. Klotho 基因真核表达载体的构建及其TCMK-1 细胞中的稳定表达. 上海交通大学学报（医学版）, 2014,34(5):567-572.
128. 周健,陶磊，张铎，陈斌，汤纬晶，路丽明*. 白介素10 单核苷酸多态性与声带白斑易感性研究中华耳鼻咽喉头颈外科杂志2013, 48: 1017-1021 通讯作者
129. 周琳,周光炎,路丽明*.辅助性T细胞亚群的多样性与分化的可塑性研究[J].中国免疫学杂志,2013,29(06):653-656.
130. 张铎，路丽明，陈斌，李青，周健，陶磊.天花粉蛋白通过抑制核因子κB促进顺铂诱导喉癌细胞凋亡的研究. 中华耳鼻咽喉头颈外科杂志, 2013, 48(4): 322-328.
131. 张铎，陶磊，路丽明*. 天花粉蛋白诱导肿瘤细胞凋亡和其它抗肿瘤作用机制及研究进展。复旦大学学报（医学版）。2012，39（6）：663-667
132. 周琳，周光炎，路丽明*. IL-10 的双向免疫调节作用细胞与分子免疫学杂志,2012,28(10):1100-1102.
133. 陈斌，陶磊，周梁，周光炎，路丽明*. CD4+CD25+Foxp3+Treg 细胞与喉癌发病的相关研究现代免疫学2012, 32: 40-46 通讯作者
134. 李青，周光炎，路丽明*. 天花粉蛋白抑制同种异体混合淋巴细胞反应与诱导IL9+IL10+IL24+Th9 细胞间关系的初步探讨。现代免疫学2012, 32(2): 94-98 通讯作者
135. 邵晓轶, 马妍慧, 路丽明*等. B7H1-lg 诱导 Tr1 细胞向 CD4^+ CD25^+ Foxp3^+ Treg 细胞转化的研究. 现代免疫学, 2012, 6: 001.
136. 邵晓轶, 周芸, 路丽明*. p38 MAPK 信号通路在 B7H1-Ig 融合蛋白诱导 Tr1 细胞分化中的作用.上海交通大学学报 (医学版), 2012, 32(11): 1448.
137. 邵晓轶, 路丽明*, 周芸等. 小鼠膜型 B7-H1 分子激活同种异体 Tr1 细胞介导免疫抑制. 南通大学学报: 医学版, 2012, 32(5): 333-337.
138. 李青，周光炎，路丽明*. Th9：亚群特征、相关转录因子及其分化的可塑性。现代免疫学2011,31:340-343 通讯作者
139. 李青，周光炎，路丽明*. IL-9 的研究进展。中国免疫学杂志2011, 27:848-850 通讯作者
140. 陈斌，路丽明，陶磊，周梁，李诗敏，朱莉.趋化因子受体CCR6及CCR7在喉鳞状细胞癌中表达的研究[J].临床耳鼻咽喉头颈外科杂志,2010,24(21):975-979.
141. 陈斌，路丽明，陶磊，周梁，李诗敏，朱莉. 趋化因子受体6和7与CD4+ CD25+ Foxp3+调节性T细胞在喉鳞癌中的表达及其与淋巴转移的相关性.中华耳鼻咽喉头颈外科杂志, 2010, 45(9): 759-764.
142. 路丽明，丁庆，杨能，周芸，周光炎. 应用RNA 干扰阻抑小鼠L929 细胞MHC II 类基因表达及功能的研究，现代免疫学2009, 28(6): 387-392
143. 周芸,焦志军,辛利军,汪四七,路丽明,丁庆,周晓荣,杨能,周光炎.自体角朊细胞通过B7-H1介导对异种混合淋巴细胞增殖的抑制作用[J].现代免疫学,2009,29(06):486-490.
144. 王慧，杨能，周佩军，邵琨，赵菊平，徐达，王祥慧，沈周俊，路丽明，刘世雄. 混合培养的供、受者骨髓细胞过继回输延长小鼠移植心脏存活时间 , 中华器官移植杂志 2009, 30:604-607
145. 周芸，焦志军，路丽明，丁庆，扬能，周光炎. 自体角朊细胞通过诱导分泌 IL-10 的 T 细胞亚群抑制异种混合淋巴细胞增殖反应，现代免疫学 2009, 29:387-391
146. 路丽明，丁庆，扬能，周芸，周光炎. 膜型B7-H1 分子诱导产生的T 细胞及其免疫学特性的初步研究，现代免疫学2008, 28(6):465-469
147. 杨能，路丽明，周芸，周晓荣，焦志军，马妍慧，周光炎天花粉蛋白合成肽通过激活抑制性 CD8+T细胞诱导免疫抑制现代免疫学 2008,28(1). 16-20
148. 杨能,史桂英,路丽明,周芸,马妍慧,周光炎.天花粉蛋白合成肽通过诱导CD8抑制性T细胞治疗实验性自身反应性脑脊髓炎[J].现代免疫学,2008(03):199-202.
149. 辛利军,焦志军,丁庆,路丽明,周芸,周光炎.B7-H1协同刺激淋巴细胞增殖并诱导产生抑制性T细胞[J].中国免疫学杂志,2007(08):680-683+687.
150. 路丽明，丁庆，江阳等一种新的CIITA 显性负向突变体的构建和功能研究现代免疫学2006,26:116-120
151. 丁庆，路丽明，江阳等 B7H1-Ig 融合蛋白抑制作用的机制研究。现代免疫学 2006,24(6). 460-463
152. 焦志军，王保龙，路丽明，丁庆，周晓荣，江阳，周芸，辛利军，周光炎，天花粉蛋白对不同小鼠品系 T 细胞亚群分化的影响现代免疫学 2006,24(1). 12-16
153. 焦志军，周芸，辛利军，路丽明，丁庆，周晓荣，杨能，周光炎.天花粉蛋白及其肽段诱导的免疫抑制依赖 APC 表面 Notch 配体的表达现代免疫学 2006,26(6). 448-453
154. 焦志军，周芸，路丽明，丁庆，周晓荣，杨能，辛利军，周光炎. 天花粉蛋白免疫抑制作用的功能性肽段筛选及其作用机制现代免疫学 2006,26(5). 362-366
155. 曹聪，董英海，董宇启，路丽明，崔磊，刘伟，曹谊林. 人血源性间充质干细胞培养与体外成骨研究中国修复重建外科杂志 2005,19(8).642-647
156. 周洪语，路丽明，王勇，江基尧，罗其中. 榄香烯抑制脑胶质瘤细胞增殖的比较研究中国实验外科杂志 2004,21(10).1241-1243
157. 陈炜，刘伟，刘德莉，吴娟娟，路丽明，曹谊林.FasL 基因转染 Hela 细胞体外诱导淋巴细胞凋亡的作用上海第二医科大学学报 2004,24(4).279-283
158. 范华骅，郭荣，崔磊，刘伟，路丽明，曹谊林. CIITA 反义基因体外转染对 HLA-Ⅱ类抗原表达的抑制作用的研究中国临床医学.2004,11(2).174-176
159. 江阳，路丽明，丁庆. 等Ⅳ型Ⅱ类反式激活因子基因新变异体的克隆、鉴定和功能测定现代免疫学2004,24(6).-460-463
160. 李宁丽，路丽明等重组人可溶性 TRAIL 分子诱导细胞凋亡机理探讨。上海第二医科大学学报2003,23(1).10-14
161. 路丽明，李宁丽，沈佰华等TRAIL 分子胞外区基因工程蛋白的制备与鉴定，中国实验诊断学2003,7；477-479
162. 周洪语，路丽明，罗其中. SD大鼠星形胶质细胞的原代培养中华神经医学杂志.2003,2(5). 346-347
163. 路丽明，李宁丽等人可溶性TRAIL 基因的克隆及表达上海免疫学杂志2002, 22：308-312
164. 程琳玲,聂红,王利,尤强,路丽明,沈佰华,张冬青,李宁丽.人sCD40L基因的克隆及表达.细胞与分子免疫学杂志,2002(02):125-127.
课题组长
沪公网安备 31009102000053号 沪ICP备18007527号-1 邮箱：sii@shsmu.edu.cn